| Patents for C07D 249 - Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms (17,749) |
|---|
| 06/15/2005 | EP1539705A2 Novel benzohydrazide derivatives as herbicides and desiccant compositions contaning them |
| 06/15/2005 | CN1626522A Method for synthesizing triazazole kali salt of methyl benzo |
| 06/14/2005 | US6906006 Applying to plants, environment |
| 06/14/2005 | US6905804 Charge transport material comprising a fluorenone hydrazone having a) least two fluorenone alkylsulfonylphenylhydrazone groups, b) at least two fluorenone pyrrolylhydrazone groups, c) at least two fluorenone benzotriazolylhydrazone groups, d) |
| 06/09/2005 | WO2005051879A1 Process for producing epoxytriazole compound and intermediate therefor |
| 06/09/2005 | US20050124561 Administering fungicide for mucous membrane; asthma therapy |
| 06/09/2005 | US20050123849 Electrophotographic organophotoreceptors with novel charge transport materials |
| 06/09/2005 | US20050123831 used for ionic conducting materials, electronic conducting materials, colorant, and the catalysis of various chemical reactions |
| 06/08/2005 | EP1537077A2 4-(3,3-dihalo-allyloxy) phenol derivatives having pesticidal properties |
| 06/08/2005 | EP1465854A4 Chalcone derivatives and their use to treat diseases |
| 06/08/2005 | EP1458706A4 Diaryl 1,2,4-triazole derivatives as a highly selective cyclooxygenase-2 inhibitor |
| 06/08/2005 | EP1220831B1 Biaryl ether derivatives useful as monoamine reuptake inhibitors |
| 06/08/2005 | EP1019045B1 Antithrombotic agents |
| 06/08/2005 | CN1205181C Matrix metalloproteinase inhibitors |
| 06/07/2005 | US6903092 Naphthamide neurokinin antagonists for use as medicaments |
| 06/07/2005 | US6903088 Compounds which inhibit leukocyte adhesion mediated by VLA-4 |
| 06/02/2005 | WO2005049589A2 Heterocyclic compounds for the treatment of hyperlipidemia, diabetes, obesity and similar diseases |
| 06/02/2005 | US20050119312 Lipid lowering agents; hypotensive agents; obesity |
| 06/02/2005 | US20050119304 N-[4-chloro-3-(trifluoromethyl)phenyl]-N'-(1H-indazol-5-yl)urea; vanilloid receptor (VR1) antagonist; blockage of neurotransmitter release |
| 06/02/2005 | US20050119261 Analgesics; neuropathic pain; antiepileptic agents; irritable bowel syndrome; antidepressants; anxiolytic agents; multiple sclerosis; bipolar disorders |
| 06/02/2005 | US20050119250 Amino-derivatives as novel inhibitors of histone deacetylase |
| 06/02/2005 | DE10143521B4 Additionsprodukt, seine Herstellung und seine Verwendung als Korrosionsinhibitor Addition product, its preparation and its use as a corrosion inhibitor |
| 06/01/2005 | EP1535914A1 Processes for producing epoxytriazole derivative and intermediate therefor |
| 06/01/2005 | EP1535909A2 Cyclic amine derivatives and their use as drugs |
| 06/01/2005 | EP1534693A2 1, 3-diamino-2-hydroxypropane prodrug derivatives |
| 06/01/2005 | EP1534689A1 Novel carboxamide compounds having an mch-antagonistic effect, medicaments containing said compounds, and methods for the production thereof |
| 06/01/2005 | EP1534265A1 Combination of an aromatase inhibitor with a bisphosphonate |
| 06/01/2005 | EP1254136A4 FACTOR Xa INHIBITORS WITH ARYL-AMIDINES AND DERIVATIVES, AND PRODRUGS THEREOF |
| 06/01/2005 | EP1095015B1 Sulfonylamino carboxylic acid n-arylamides as guanylate cyclase activators |
| 06/01/2005 | EP1009758B1 Meta-benzamidine derivatives as serine protease inhibitors |
| 06/01/2005 | EP0991625B1 Inhibitors of factor xa with a neutral p1 specificity group |
| 06/01/2005 | CN1204182C Cooperative action mixture of UV absorbent in polyolefine |
| 05/31/2005 | US6900218 Reducing oxidation stresses; central nervous system disorders; antiinflammatory agents |
| 05/26/2005 | WO2005047899A2 Use of the lipoxin receptor, fprl1, as a tool for identifying compounds effective in the treatment of pain and inflammation |
| 05/26/2005 | WO2005047270A2 Substituted triazoles as sodium channel blockers |
| 05/26/2005 | WO2005047269A1 A method for the separation of the letrozole precursor 4-‘1-(1,2,4-triazolyl) methyl!benzonitrile from its 1,3,4-triazolyl isomer |
| 05/26/2005 | WO2005047237A1 Method for synthesising diaryl sulphide compounds in a solid phase |
| 05/26/2005 | US20050113580 2-(3-{3-[[2-chloro-3-(trifluoromethyl)benzyl](2,2-dephenylethyl)amino]propoxy}phenyl)-ethanol; agonists of the nuclear receptors, LXR alpha and LXR beta used to increase ABCA1, ABCG1, and apolipoprotein E expression and inhibiting cholesterol absorption |
| 05/26/2005 | US20050113450 method of sterilization, sanitation, antisepsis, and disinfection, includes applying antimicrobial compounds to a surface; e.g. 2-[(3-{[4-chloro(methyl)anilino]sulfonyl}benzoyl)amino]-5-(trifluoromethyl)benzoic acid |
| 05/26/2005 | US20050113432 Bis(cyanophenyl)methyl-triazole for use in prevention of breast cancer |
| 05/26/2005 | US20050113357 Cholinergic agents such as 3-[3-(4-methoxypiperidine)-1-yl-propyl]-1H-indole; for therapy of cognitive dysfunction, forgetfulness, confusion, memory loss, attention deficits, deficits in visual perception, depression, pain, sleep disorders, and psychosis |
| 05/26/2005 | US20050113347 Novel antibacterial compounds: process for their preparation and pharmaceutical compositions containing them |
| 05/26/2005 | US20050112407 Organic electroluminescent device |
| 05/26/2005 | CA2545254A1 Substituted triazoles as sodium channel blockers |
| 05/26/2005 | CA2544983A1 Use of the lipoxin receptor, fprl1, as a tool for identifying compounds effective in the treatment of pain and inflammation |
| 05/25/2005 | EP1533292A1 Dibenzylamine compound and medicinal use thereof |
| 05/25/2005 | EP1532122A1 11-beta-hydroxysteroid dehydrogenase 1 inhibitors useful for the treatment of diabetes, obesity and dyslipidemia |
| 05/25/2005 | EP1531822A1 1-aryl-4-substituted piperazine derivatives for use as ccr1 antagonists for the treatment of inflammation and immune disorders |
| 05/25/2005 | EP1531810A2 Substituted heterocyclic derivatives useful as antidiabetic and antiobesity agents and method |
| 05/25/2005 | CN1620424A Compounds for the treatment of inflammatory disorders |
| 05/25/2005 | CN1203047C Biaryl ether derivatives useful as monoamine reuptake inhibitors |
| 05/19/2005 | WO2005044785A1 Aralkyl amines as cannabinoid receptor modulators |
| 05/19/2005 | WO2005044192A2 Triazole compounds and uses related thereto |
| 05/19/2005 | WO2005044007A1 Biphenyl derivative or its salt, and pesticide containing it as an active ingredient |
| 05/19/2005 | US20050107444 E.g., 2-(3-{3-[(2-chloro-3-(trifluoromethyl)-benzyl)-(2,2-diphenylethyl)-amino]-propoxy}phenyl)-1-morpholin-4-yl-ethanone; agonists of the nuclear receptors, LXR alpha and LXR beta used to increase ABCA1, ABCG1, and apolipoprotein E expression and inhibiting cholesterol absorption |
| 05/19/2005 | US20050107384 to inhibit proliferative conditions, such as cancer and psoriasis; detecting or identifying a HDAC in a biological sample comprising detecting or measuring the formation of a complex between a labelled compound as defined in claim (I) and a HDAC |
| 05/19/2005 | US20050107383 such as 2-(2-propenylthio)-4-(4-trifluoromethylphenyl)benzonitrile; for farm and garden pests including mites, lepidopterans, hemipterans, hymenopterans, orthopterans and isopterans; antiviral agent, fungicide, herbicide |
| 05/19/2005 | US20050107382 e.g. 2-(4-fluoro-2-methylphenyl)-5-(5-methoxymethyl-4-(6-methoxypyridin-3-yl)-4H-[1,2,4]triazol-3-yl)-pyridine; treatment of arousal disorder, orgasmic disorder, sexual pain disorder and premature ejaculation, preterm labor, appetite and feeding disorders, dysmenorrhoea, congestive heart failure, etc. |
| 05/19/2005 | US20050107345 Aminoalkylphosphonates and related compounds as edg receptor agonists |
| 05/19/2005 | CA2543882A1 Aralkyl amines as cannabinoid receptor modulators |
| 05/19/2005 | CA2543602A1 Triazole compounds and uses related thereto |
| 05/18/2005 | CN1617859A 5-sulfanyl-4h-1, 2, 4-triazole derivatives and their use as a medicament |
| 05/18/2005 | CN1617852A Alpha-(n-sulphonamido)acetamide derivatives as beta-amyloid inhibitors |
| 05/18/2005 | CN1617850A Dibenzylamine compound and medicinal use thereof |
| 05/18/2005 | CN1202095C Heteroaromatic ring compounds |
| 05/18/2005 | CN1202089C Method for producing 2-(1,2,4-triazol-1-YL)-ethanols |
| 05/17/2005 | US6894054 Central nervous system disorders; muscular disorders |
| 05/17/2005 | US6893774 For use in electrolytes, primary batteries, secondary batteries, capacitors, supercapacitors or galvanic cells |
| 05/17/2005 | US6893650 Fungicides; locus infestation; such as N,N-dimethyl-N'-(4-(3-trifluoromethylbenzylthio)-2,5-xylyl)formamidine |
| 05/17/2005 | US6893471 For dyeing human hair |
| 05/17/2005 | CA2103845C 9-[(substituted glycyl)-amido]-6-demethyl-6-deoxytetracyclines |
| 05/12/2005 | WO2005021490A3 N-SULFONYL-α-AMINO-ACID DERIVATIVES |
| 05/12/2005 | WO2004092145A8 Alpha substituted carboxylic acid as ppar modulators |
| 05/12/2005 | US20050101783 N-(heterocycle-methyl)alkylamine derivative, process for producing the same, and bactericide |
| 05/12/2005 | US20050101772 Non-metallocenes, method for the production thereof and the use thereof for the polymerisation of olefins |
| 05/11/2005 | EP1309563B1 Heterocyclic-hydroxyimino-fluorenes and their use for inhibiting protein kinases |
| 05/11/2005 | EP0973752B1 Heterocyclically substituted aromatic amino compounds with a herbicidal effect |
| 05/11/2005 | CN1613852A Cesium triazoleamide compounds and their preparation and use |
| 05/11/2005 | CN1200940C Triazole pyrimidine compounds |
| 05/11/2005 | CN1200609C Substituted aminomethyl phenyl sulphonyl ureas, their production and their use as herbicides and plant growth regulators |
| 05/10/2005 | US6890956 Cyclohexyl sulphones as gamma-secretase inhibitors |
| 05/06/2005 | WO2005040138A1 Substituted benzylaminoalkylene heterocycles |
| 05/06/2005 | WO2005039569A1 5-substituted 2-(phenylmethyl) thio-4-phenyl-4h-1,2,4-triazole derivatives and related compounds as gaba-agonists for the treatment of urinary incontinence and related diseases |
| 05/06/2005 | WO2004113394A3 Living radical polymerization initiator comprising a functional group capable of reacting with polypeptides or the like, comb polymer obtained therewith, polypeptide conjugates and drugs obtained therefrom |
| 05/06/2005 | CA2542695A1 Substituted benzylaminoalkylene heterocycles |
| 05/06/2005 | CA2542682A1 5-substituted 2-(phenylmethyl) thio-4-phenyl-4h-1,2,4-triazole derivatives and related compounds as gaba-agonists for the treatment of urinary incontinence and related diseases |
| 05/05/2005 | US20050096468 Inhibitors of histone deacetylase |
| 05/04/2005 | EP1527053A1 Process for preparing rizatriptan |
| 05/04/2005 | EP1527041A1 Process for the preparation of primary amines |
| 05/04/2005 | EP1232148B1 Use of benzotriazole uv absorbers |
| 05/04/2005 | CN1612865A Triazole derivatives as cyclooxygenase (COX) inhibitors |
| 05/04/2005 | CN1611507A N-(phosphonomethyl) aminoacetate, preparation and using method thereof |
| 05/03/2005 | US6888004 Imidazolyl derivatives as corticotropin releasing factor inhibitors |
| 05/03/2005 | CA2236208C Substituted sulphonylamino (thio)carbonyl compounds as herbicides |
| 04/28/2005 | WO2004014844A3 Aryl and heteroaryl compounds and methods to modulate coagulation |
| 04/28/2005 | US20050090555 Compound for the treatment of metabolic disorders |
| 04/27/2005 | EP1524905A1 Crystal modification ii of 2- 2-(1-chloro-cyclopropyl)-3-(2-chlorophenyl)-2-hydroxy-propyl]-2,4-dihydro-3h-1,2,4-triazole-3-thions |
| 04/27/2005 | EP1011651B1 Method of treating diabetes and related disease states |
| 04/27/2005 | EP0838453B1 Heterocyclic carboxylic acid derivatives and drugs containing the same |
| 04/27/2005 | CN1198808C Use of benzotriazole UV absorbers |